Passengers aboard the MV Hondius finally stepped onto dry land in Tenerife after spending weeks at sea during a hantavirus outbreak that drew global attention and growing concern. From early morning,... Read more »
As concerns rise over the recent hantavirus outbreak linked to a cruise ship, health authorities continue to reassure the public that the situation is not comparable to the Covid-19 pandemic. Officials... Read more »
The drugs known as GLP-1 receptor agonists have reshaped conversations about weight management, diabetes treatment, and cardiovascular medicine over the past several years. Medications like Ozempic and Mounjaro have attracted enormous... Read more »
The official death toll from the early years of the COVID-19 pandemic was already staggering. A new study suggests it was also significantly incomplete — and that the people most likely... Read more »
The director of the National Institutes of Health, Jay Bhattacharya, has been assigned to temporarily oversee the Centers for Disease Control and Prevention while the administration searches for a permanent leader.... Read more »
A key meeting of the Centers for Disease Control and Prevention’s independent vaccine advisory panel has been called off just days before it was scheduled to take place. A spokesperson for... Read more »
Many men harbor significant anxiety about whether bicycle riding could negatively impact their prostate health or sexual performance. These worries intensified during recent years as stationary bike sales surged. One urologist shares... Read more »
Pharmaceutical manufacturer Novo Nordisk announced Monday that its widely-used weight-loss medication Wegovy is now accessible in pill form, beginning with the starter dosage. Additional strength options will become available in pharmacies... Read more »
Why do most wellness commitments collapse before spring arrives? The answer isn’t laziness or weak resolve—it’s flawed methodology. Traditional goal-setting demands dramatic lifestyle renovations powered solely by determination, an approach destined... Read more »
U.S. health authorities have informed executives at Merck, Sanofi, and AstraZeneca that their infant RSV therapies will undergo renewed safety scrutiny. The decision comes amid heightened attention from U.S. Health Secretary Robert... Read more »